Last reviewed · How we verify
NCT07499934: EMIP
Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study
NA trial testing Qualitative interview in Clinical High Risk for Psychosis (CHR) in 20 participants. Currently enrolling.
19 January 2027
Quick facts
| Lead sponsor | Centre Psychothérapique de Nancy |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 19 January 2026 |
| Primary completion | 19 January 2027 |
| Estimated completion | 19 July 2027 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Qualitative interview
Conditions studied
- Clinical High Risk for Psychosis (CHR) — all drugs for Clinical High Risk for Psychosis (CHR) →
Sponsor
Centre Psychothérapique de Nancy
Who can join
Adults 15 to 30, any sex, with Clinical High Risk for Psychosis (CHR). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this qualitative study is to explore and describe the lived experiences of individuals at ultra-high risk (UHR) or first episode of psychosis (FEP) who have participated in a group-based mindfulness-based intervention. Secondary objectives include identifying potential adverse effects of a group-based mindfulness-based intervention among UHR or FEP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07499934
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Qualitative interview
Trials testing the same drug.
- NCT06815120 — A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent · NA · not yet recruiting
- NCT06357845 — Linking Somatic Mutation Rate With Baseline Exposure in East Palestine · NA · recruiting
- NCT06330350 — Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling · recruiting
- NCT05887271 — A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejec · Phase 2, PHASE3 · recruiting
- NCT06083597 — Development of a Patient-reported Outcome Measure for Women With Chronic Pelvic Pain · enrolling by invitation
Other recruiting trials for Clinical High Risk for Psychosis (CHR)
Currently open trials in the same condition.
- NCT06582901 — Interventions for Clinical High Risk Youth in Tunisia · NA · recruiting
- NCT05968560 — Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis · NA · recruiting
Other Centre Psychothérapique de Nancy trials
Trials by the same sponsor.
- NCT06532604 — Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder · NA · not yet recruiting
- NCT06649552 — French Validation of Schizophrenia Proneness Instrument- Child Youth · NA · not yet recruiting
- NCT06361407 — Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia · NA · recruiting
- NCT06330467 — Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma. · NA · recruiting
- NCT05966077 — Impact of Sending an Sms on the Rate of Telephone Responses of Subjects Contacted 3 Months After the Suicidal Act · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07499934 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Psychothérapique de Nancy
- Last refreshed: 30 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07499934.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing